Renishaw (LSE:RSW), the precision measurement and healthcare technology group, is in the spotlight following final results published on 23 September that showed a marked recovery in profitability. The FTSE 250 engineer combined double-digit Revenue growth with a three-percentage-point improvement in its adjusted operating margin, rewarded shareholders with a special dividend, and said its 2027 financial year had started well. A director dealing announcement followed at the end of September.
Growth across all three segments
In the year to 30 June 2026, revenue rose 14% to £815.8m, or 17% at constant exchange rates. Adjusted operating profit increased 36% to £152.9m, lifting the adjusted Operating Margin to 18.7% from 15.7%. Adjusted profit before tax climbed 32% to £168.0m, while statutory profit before tax rose 27% to £150.0m after £18.0m of redundancy and other one-off costs. Adjusted Earnings Per Share rose 30% to 179.5p.
The fourth quarter was particularly solid, with record revenue of £244.2m, 28% higher than a year earlier. Position Measurement, which supplies encoders and related products, grew revenue 26% to £260.9m and expanded its margin to 27.4%. Specialised Technologies, which includes additive Manufacturing and healthcare products, grew 43% to £107.5m and moved back into profit. The larger Industrial Metrology segment grew 4% to £447.4m, with a broadly stable margin.
Regionally, the Americas led the way with constant-currency growth of 35%, followed by Asia-Pacific at 17%, while Europe, the Middle East and Africa grew 3%.
Dividends and cash
The board proposed a final dividend of 65.2p, taking the ordinary payout for the year to 82.0p, up 5%. It also approved a Special Dividend of 70.0p per share, paid as an interim dividend. Cash and deposits rose to £291.0m, even though adjusted cash conversion fell to 79% from 91% as Working Capital increased to support record orders. Capital Expenditure fell to £38.3m, and return on invested capital improved to 17.5%. A cost-reduction programme delivered around £20m of savings during the year.
Drivers and outlook
Management credited accelerating Demand from semiconductor manufacturing and aerospace and defence customers, alongside growing traction for newer product lines such as additive manufacturing. Investment by chipmakers in new capacity, much of it linked to artificial intelligence, has benefited several UK-listed equipment and component suppliers this year, and Renishaw's encoder and metrology products are exposed to that cycle.
Looking ahead, the company said the 2027 financial year had started well and that it expects further progress in revenue, profit and operating margin. The chief financial officer indicated that further margin improvement is anticipated. Risks include the cyclicality of semiconductor capital spending, currency movements given Renishaw's large overseas sales, and the broader trade environment.
The improvement in Specialised Technologies is also notable. The segment, which had posted an adjusted operating loss of £9.9m in the previous year, swung to a profit of £4.7m, suggesting that newer product lines are beginning to contribute rather than dilute returns. Impairment charges rose to £8.8m from £2.8m, however, a reminder that not every development area has delivered. Management will need to show that the margin gains achieved through cost savings and firmer volumes can be held if demand from semiconductor customers cools.
The founding family's significant shareholding continues to shape the register, and the company has a history of conservative Balance Sheet management, which the special dividend reflects. The next scheduled update is likely to be the Annual General Meeting later in the autumn.




_11_18_2026_14_55_02_703826.jpg)

Please wait processing your request...